SCHEMBL3519503

SCHEMBL3519503

COC(=O)c1c(OC)c(Br)cc2ncc(=O)[nH]c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.38
HTT P42858 2/20 0.38
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
XDH P47989 1/20 0.34
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
POLB P06746 1/20 0.32
LMNA P02545 1/20 0.32
TPMT P51580 1/20 0.32
CYP19A1 P11511 1/20 0.32
NGFR P08138 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1081072 0.80 HPGD (0.35) TSHRHTTXDHMAPTHPGD
SCHEMBL3520193 0.80 GRIN2D (0.38) TSHRHTTGRIN2DGRIN3BGRIN1
SCHEMBL18739492 0.77 XDH (0.42) TSHRXDHCYP1A2HSD17B10POLB
SCHEMBL3517844 0.76 RPS6KB1 (0.41) GRIN1GRIN2BGABRA5GSK3BDYRK1A
SCHEMBL4113651 0.72 CA2 (0.48) TSHRHTTMAPTHPGDHSD17B10
SCHEMBL3521595 0.71 MAPT (0.37) TSHRHTTMAPTHPGDHSD17B10
SCHEMBL3517937 0.70 TSHR (0.37) TSHRHTTMAPTHPGDHSD17B10
SCHEMBL3523124 0.69 POLB (0.39) TSHRHTTMAPTHPGDHSD17B10
SCHEMBL3518631 0.68 SMN1; SMN2 (0.45) CYP1A2MAPTSMN1; SMN2GABRA1GABRG2
SCHEMBL17410569 0.67 KMT2A (0.40) TSHRHTTMAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101983384-A Prolyl hydroxylase inhibitors SMITHKLINE BEECHAM CORP 2011-03-02 CN disclosed
US-20100305133-A1 Prolyl Hydroxylase Inhibitors SMITHKLINE BEECHAM CORPORATION 2010-12-02 US disclosed
EP-2227770-A2 PROLYL HYDROXYLASE INHIBITORS GlaxoSmithKline LLC (US) 2010-09-15 EP disclosed
WO-2009073497-A2 PROLYL HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305133-A1 Prolyl Hydroxylase Inhibitors HIF1AN, EGLN3, EGLN2 TSHR 2760/4885HTT 2129/4885GRIN2D 4652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.